Evenity, used to treat osteoporosis, has a boxed warning from the FDA due to increased risk of stroke, heart attack, and cardiovascular death. It’s important to promptly report symptoms like chest ...
THOUSAND OAKS, Calif. and BRUSSELS, April 9, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
MISSISSAUGA, ON, Oct. 8, 2019 /CNW/ - Today Amgen Canada announced that EVENITY ® (romosozumab) is now available in Canada for the treatment of osteoporosis in postmenopausal women at high risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results